Haim Barr

Weizmann Institute of Science — Israel

Computer Science · Physical Sciences

23h-index3.2kcitations102works1.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Computational Drug Discovery Methods(12), SARS-CoV-2 and COVID-19 Research(10), Click Chemistry and Applications(10), Protein Degradation and Inhibitors(10), Histone Deacetylase Inhibitors Research(9)

Publications101 total

A Computational Community Blind Challenge on Pan-Coronavirus Drug Discovery Data
Journal of Chemical Information and Modeling·2026
Linking biochemical and cellular efficacy of MERS coronavirus main protease inhibitors
2026Open Access
A pharmacological modality to sequester homomeric proteins
Nature Chemical Biology·2026· 1 citedOpen Access
A Computational Community Blind Challenge on Pan-Coronavirus Drug Discovery Data
2026Open Access
A Computational Community Blind Challenge on Pan-Coronavirus Drug Discovery Data
2025Open Access
Neutralization and assessment of the binding capacity of maternal sera against various SARS-CoV-2 variants
Placenta·2025
Combined crystallographic fragment screening and deep mutational scanning enable discovery of Zika virus NS2B-NS3 protease inhibitors
Nature Communications·2025· 5 citedOpen Access
A Computational Community Blind Challenge on Pan-Coronavirus Drug Discovery Data
2025· 1 citedOpen Access
A Computational Community Blind Challenge on Pan-Coronavirus Drug Discovery Data
2025Open Access
A Computational Community Blind Challenge on Pan-Coronavirus Drug Discovery Data
2025Open Access
A high-throughput zebrafish screen identifies novel candidate treatments for kaposiform lymphangiomatosis (KLA)
The Journal of Experimental Medicine·2025· 1 cited
Antiferroptotic Drugs Reduce sFlt-1 Release and Placenta Damage in Preeclampsia
Hypertension·2025· 3 cited
A Structure-Based Computational Pipeline for Broad-Spectrum Antiviral Discovery
2025· 2 citedOpen Access
A Computational Community Blind Challenge on Pan-Coronavirus Drug Discovery Data
2025· 2 citedOpen Access
Discovery of orally bioavailable Zika and West Nile Virus antiviral compounds targeting the NS2B-NS3 protease
2025· 2 citedOpen Access
Open-science discovery of DNDI-6510, a compound that addresses genotoxic and metabolic liabilities of the COVID Moonshot SARS-CoV-2 Mpro lead inhibitor
2025· 3 citedOpen Access
Abstract LB457: Suppressing liver metastasis growth by inducing the endogenous expression of the tumor suppressor miR-34a by small synthetic molecules
Cancer Research·2025
Crystallographic fragment screening and deep mutational scanning of Zika virus NS2B-NS3 protease enable development of resistance-resilient inhibitors
2025· 1 citedOpen Access
ZIKV NS2B-NS3 protease dose response screening assay v1
2024Open Access
ZIKV NS2B-NS3 fluorescence single point screening assay v1
2024Open Access
page 1 of 6Next →

Frequent Co-authors

Nir London(17), A.N. Plotnikov(13), Galit Cohen(10), Ronen Gabizon(9), F. von Delft(9), Noga Kozer(9), Efrat Resnick(8), Shirly Duberstein(8), D. Fearon(8), Khriesto A. Shurrush(8), Paul Gehrtz(6), Ziv Shulman(6), Alpha A. Lee(6), A. Douangamath(5), M. Fairhead(5), Daniel Zaidman(5), Sílvia Carvalho(5), T. Krojer(4), A. Aimon(4), Gabriel Amitai(4)